The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation
Abstract
Although the role of the T(H)1 and T(H)17 subsets of helper T cells as disease mediators in autoimmune neuroinflammation remains a subject of some debate, none of their signature cytokines are essential for disease development. Here we report that interleukin 23 (IL-23) and the transcription factor RORγt drove expression of the cytokine GM-CSF in helper T cells, whereas IL-12, interferon-γ (IFN-γ) and IL-27 acted as negative regulators. Autoreactive helper T cells specifically lacking GM-CSF failed to initiate neuroinflammation despite expression of IL-17A or IFN-γ, whereas GM-CSF secretion by Ifng(-/-)Il17a(-/-) helper T cells was sufficient to induce experimental autoimmune encephalomyelitis (EAE). During the disease effector phase, GM-CSF sustained neuroinflammation via myeloid cells that infiltrated the central nervous system. Thus, in contrast to all other known helper T cell-derived cytokines, GM-CSF serves a nonredundant function in the initiation of autoimmune inflammation regardless of helper T cell polarization.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Th2 cells regulate multiple non-immune tissue cells at mucosal sites”
From TH17 cell heterogeneity and its role in tissue inflammation (2023) · cites this paper as [25]
In the citing paper
“GM-CSF is essential for the development and progression of EAE. Mice deficient in GM-CSF are resistant to EAE induction, and blockade of GM-CSF in wild-type mice suppresses ongoing disease (McQualter et al., 2001; Codarri et al., 2011).”
From The Role of Iron Regulation in Immunometabolism and Immune-Related Disease (2019) · cites this paper as Codarri et al., 2011
Citations
Cites
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906
Oppmann, B., Lesley, R., Blom, B., Timans, J. C., Xu, Y., Hunte, B., Vega, F., Yu, N., Wang, J., Singh, K. P., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)00070-4 · Cited by 2,819
IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells
Korn, T., Bettelli, E., Gao, W., Awasthi, A., Jäger, A., Strom, T. B., Oukka, M., & Kuchroo, V. K. (2007) · Nature · doi:10.1038/nature05970 · Cited by 1,896
Aggarwal, S., Ghilardi, N., Xie, M.-H., de Sauvage, F. J., & Gurney, A. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207577200 · Cited by 1,848
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 1,001
Hiltensperger, M., & Korn, T. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a029637 · Cited by 45
“IL-23 induces the expression of granulocytemacrophage colony-stimulating factor (GM-CSF) in Th17 cells (Codarri et al. 2011; El-Behi et al. 2011), although the expression of GM-CSF is not restricted to Th17 cells (Grifka-Walk et al.”
BackgroundRyan, L., & Mills, K. H. G. (2021) · European Journal of Immunology · doi:10.1002/eji.202149589 · Cited by 48
Tatović, D., Marwaha, A., Taylor, P. N., Hanna, S. J., Carter, K., Cheung, W., Luzio, S. D., Dunseath, G. J., Hutchings, H. A., Holland, G., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-03115-2 · Cited by 53
“It is interesting that, in multiple sclerosis, GM-CSF seems to play an active role in initiation of central nervous system inflammation 42 because autoreactive T cells that lack GM-CSF fail to initiate neuroinflammation despite IL-17 and IFNγ production 43 .”
BackgroundLithium Controls Central Nervous System Autoimmunity through Modulation of IFN-γ Signaling
Rowse, A. L., Naves, R. F., Cashman, K. S., McGuire, D. J., Mbana, T., Raman, C., & Sarno, P. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052658 · Cited by 42
“GM-CSF is a key pathogenic determinant of encephalitogenic Th17 cells and its elevation by lithium treatment is consistent with treatment inefficacy [27,28].”
BackgroundCharacterization of pathogenic human monoclonal autoantibodies against GM-CSF
Wang, Y., Thomson, C. A., Allan, L. L., Jackson, L. M., Olson, M., Hercus, T. R., Nero, T. L., Turner, A. L., Parker, M. W., Lopez, A. L. C., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1216011110 · Cited by 43
Tang, W.-H., Wang, H.-S., Claudio, E., Tassi, I., Ha, H., Saret, S., & Siebenlist, U. (2014) · Immunity · doi:10.1016/j.immuni.2014.09.017 · Cited by 43
“IL-23 may furthermore drive the pathogenicity of autoreactive T cells by inducing production of GM-CSF (Codarri et al., 2011; El-Behi et al., 2011).”
Hou, L., & Yuki, K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.819224 · Cited by 45
Tob1 plays a critical role in the activation of encephalitogenic T cells in CNS autoimmunity
Schulze‐Topphoff, U., Casazza, S., Varrin‐Doyer, M., Pekarek, K. L., Sobel, R. A., Hauser, S. L., Oksenberg, J. R., Zamvil, S. S., & Baranzini, S. E. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20121611 · Cited by 43
“Approximately 80% of CIS patients develop clinically definite MS (CDMS) within 3 yr (half within 2 yr), and only 10% do not advance to MS after 15 yr (Brex et al., 2002; Hauser and Goodin, 2012).”
BackgroundPathogenic IL‐23 signaling is required to initiate GM‐CSF‐driven autoimmune myocarditis in mice
Wu, L., Diny, N. L., Ong, S., Barin, J. G., Hou, X., Rose, N. R., Talor, M. V., & Čiháková, D. (2015) · European Journal of Immunology · doi:10.1002/eji.201545924 · Cited by 42
Tolerance to the Intestinal Microbiota Mediated by ROR(γt) + Cells
Ohnmacht, C. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.05.002 · Cited by 45
Ulges, A., Witsch, E., Pramanik, G. K., Klein, M., Birkner, K., Bühler, U., Wasser, B., Luessi, F., Stergiou, N., Dietzen, S., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1523869113 · Cited by 42
“Another cytokine induced by IL-23 in TH17 cells is granulocyte–macrophage colony-stimulating factor (GM-CSF), which essentially contributes to CNS inflammation (16).”
BackgroundCCL17 in Inflammation and Pain
Lee, M.-C., Jarnicki, A., Achuthan, A. A., Fleetwood, A. J., Anderson, G. P., Ellson, C. D., Feeney, M. B., Modis, L. K., Smith, J. E., Hamilton, J. A., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000315 · Cited by 42
Type 17 immunity promotes the exhaustion of CD8+ T cells in cancer
Kim, B. S., Kuen, D., Koh, C., Kim, H., Chang, S. H., Kim, S., Jeon, Y. K., Park, Y.-J., Choi, G., Kim, J., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-002603 · Cited by 44
Blakely, P. K., Hussain, S., Carlin, L. E., & Irani, D. N. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00344 · Cited by 42
“*p < 0.05 compared to levels found in naïve spinal cord. also potently increased SPARCL1 levels (Figure 6E), even though it also serves as an important effector in Th17-driven EAE by mobilizing myeloid cells to the CNS (Kroenke et al., 2008; Codarri et al., 2011).”
BackgroundInfluentialBuzzard, K. A., Broadley, S., & Butzkueven, H. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms131012665 · Cited by 51
Liu, Y., Gibson, S. A., Benveniste, E. N., & Qin, H. (2015) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2016015517 · Cited by 43
Gartlan, K. H., Varelias, A., Koyama, M., Robb, R. J., Markey, K. A., Chang, K., Wilkinson, A., Smith, D. D., Ullah, M. A., Kuns, R. D., et al. (2017) · Blood Advances · doi:10.1182/bloodadvances.2016002980 · Cited by 41
Transcriptional regulation of CD4+ TH cells that mediate tissue inflammation
Loo, T. T., Gao, Y., & Lazarevic, V. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.1ri0418-152rr · Cited by 43
The role of B cells in multiple sclerosis: Current and future therapies
Negron, A. J., Robinson, R. R., Stüve, O., & Forsthuber, T. G. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.10.006 · Cited by 46
Maschmeyer, P., Heinz, G. A., Skopnik, C. M., Lutter, L., Mazzoni, A., Heinrich, F., von Stuckrad, A. S. L., Wirth, L. E., Tran, C. L., Riedel, R., et al. (2020) · European Journal of Immunology · doi:10.1002/eji.202048797 · Cited by 41
Th17 Cells in Viral Infections—Friend or Foe?
Paiva, I. A., Badolato-Corrêa, J., Familiar-Macedo, D., & de‐Oliveira‐Pinto, L. M. (2021) · Cells · doi:10.3390/cells10051159 · Cited by 41
“Th1/17 cells that co-produce IFN-γ and IL-17 have high pathogenic potential and are also enriched in brain lesions in patients with MS [149].”
BackgroundSouza‐Moreira, L., Morell, M. H., Delgado‐Maroto, V., Pedreño, M., Martinez-Escudero, L., Caro, M., O’Valle, F., Luque, R. M., Gallo, M., de Lecea, L., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300384 · Cited by 41
“Of relevance is also the fact that cortistatin downregulated the production of GM-CSF by activated T cells, because it serves a nonredundant function in the initiation of autoimmune inflammation in EAE regardless of Th cell polarization (21).”
BackgroundKouakou, K., Schepetkin, I. A., Jun, S., Kirpotina, L. N., Yapi, A., Khramova, D. S., Pascual, D. W., Ovodov, Y. S., Jutila, M. A., & Quinn, M. T. (2013) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-13-149 · Cited by 40
“During the EAE disease effector phase, GM-CSF was reported to sustain neuroinflammation via myeloid cells that infiltrated the central nervous system [64].”
BackgroundTh1 not Th17 cells drive spontaneous MS-like disease despite a functional regulatory T cell response
Lowther, D. E., Chong, D. L. W., Ascough, S., Ettorre, A., Ingram, R. J., Boyton, R. J., & Altmann, D. M. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1159-9 · Cited by 40
Castelo‐Branco, G., Stridh, P., Guerreiro‐Cacais, A. O., Adzemovic, M. Z., Falcão, A. M., Marta, M., Berglund, R., Gillett, A., Hamza, K. H., Lassmann, H., et al. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.08.019 · Cited by 39
Computational modeling of heterogeneity and function of CD4+ T cells
Carbo, A., Hontecillas, R., Andrew, T., Eden, K. B., Mei, Y., Hoops, S., & Bassaganya-Riera, J. (2014) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2014.00031 · Cited by 43
“…provide a mechanisms through which Tregs cells reinforce the epithelial barrier (Lin et al., 2014), this same Th17 population can accumulate and produce additional mediators such as IFN γ or GM-CSF during gut inflammatory disorders (Ahern et al., 2010; Codarri et al., 2011; El-Behi et al., 2011).”
BackgroundHe, Z.-H., Wang, F., Ma, J., Sen, S., Zhang, J., Gwack, Y., Zhou, Y., & Sun, Z.-M. (2016) · Journal of Immunology · doi:10.4049/jimmunol.1600548 · Cited by 38
“Conversely, effective prevention of Th17-mediated autoimmune diseases, such as multiple sclerosis and psoriasis, depends on inhibiting Th17 differentiation (4, 17, 18, 21, 47).”
BackgroundMa, T., Wang, F., Xu, S., & Huang, J. H. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.01.028 · Cited by 38
Harnessing the Therapeutic Potential of Th17 Cells
Byström, J., Taher, T. E. I., Muhyaddin, M. S., Clanchy, F. I. L., Mangat, P., Jawad, A. S., Williams, R. O., & Mageed, R. A. (2015) · Mediators of Inflammation · doi:10.1155/2015/205156 · Cited by 41
“Furthermore, two recent studies revealed that, in EAE and in patients with MS, GM-CSF is produced by a separate T cell subset than byTh17 cells [95, 96].”
BATF-dependent IL-7RhiGM-CSF+ T cells control intestinal graft-versus-host disease
Ullrich, E., Abendroth, B., Rothamer, J., Huber, C., Büttner-Herold, M., Buchele, V., Vogler, T., Longerich, T., Zundler, S., Völkl, S., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci89242 · Cited by 36
“GM-CSF has been implicated as a critical T cell–derived effector cytokine that drives immunemediated diseases such as multiple sclerosis (27, 28).”
BackgroundModulation of PKM Activity Controls Differentiation of Th17 Cells
Seki, S. M., Posyniak, K., McCloud, R. L., Rosen, D. A., Fernández-Castañeda, A., Beiter, R. M., Serbulea, V., Nanziri, S. C., Hayes, N. W., Spivey, C., et al. (2019) · Science Signaling · doi:10.1126/scisignal.aay9217 · Cited by 38
“In experimental autoimmune encephalomyelitis (EAE), a mouse model for MS, genetic or pharmacologic interventions that target RORT (7, 8, 11), Hif-1 (9, 12), STAT3 (10), IL-17A (13), or GM-CSF (14) all ameliorate disease.”
BackgroundInfluentialMultiple sclerosis: Immunopathological heterogeneity and its implications
Engelhardt, B., Comabella, M., & Chan, A. (2022) · European Journal of Immunology · doi:10.1002/eji.202149757 · Cited by 42
Emerging new roles of Th17 cells
Kuchroo, V. K., & Awasthi, A. (2012) · European Journal of Immunology · doi:10.1002/eji.201242872 · Cited by 39
Immunostimulatory conventional dendritic cells evolve into regulatory macrophage-like cells
Diao, J., Mikhailova, A., Tang, M., Gu, H., Zhao, J., & Cattral, M. S. (2012) · Blood · doi:10.1182/blood-2011-11-392894 · Cited by 39
IL-21R signaling is critical for induction of spontaneous experimental autoimmune encephalomyelitis
Lee, Y., Mitsdoerffer, M., Xiao, S., Gu, G., Sobel, R. A., & Kuchroo, V. K. (2015) · Journal of Clinical Investigation · doi:10.1172/jci75933 · Cited by 37
Carlson, T. J., Pellerin, A., Djuretic, I. M., Trivigno, C., Koralov, S. B., Rao, A., & Sundrud, M. S. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302316 · Cited by 37
“mice, where direct molecular analysis of IL-23–mediated signal transduction is not possible (12, 21, 22).”
BackgroundIL-27, but not IL-35, inhibits neuroinflammation through modulating GM-CSF expression
Casella, G., Finardi, A., Descamps, H. C., Colombo, F., Maiorino, C., Ruffini, F., Patrone, M., Degano, M., Martino, G., Muzio, L., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-16702-w · Cited by 38
Sumoylation of RORγt regulates TH17 differentiation and thymocyte development
He, Z., Zhang, J., Huang, Z., Du, Q., Li, N., Zhang, Q., Chen, Y., & Sun, Z. (2018) · Nature Communications · doi:10.1038/s41467-018-07203-z · Cited by 38
Nur, S., Sparber, F., Lemberg, C., Guiducci, E., Schweizer, T. A., Zwicky, P., Becher, B., & LeibundGut‐Landmann, S. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1008115 · Cited by 38
“and acanthosis [19] and that IL-23 can drive GM-CSF production, which is essential for the induction of EAE [16,17].”
BackgroundKwiatkowski, A. J., Stewart, J. M., Cho, J. J., Avram, D., & Keselowsky, B. G. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.202000164 · Cited by 43
Hosseini, S. A., Nematollahi, S., Husain, D., Banaei-Jahromi, N., Majdinasab, N., & Hosseini, S. A. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.901846 · Cited by 40
“Some animal studies have also shown that the progression of experimental allergic encephalomyelitis (EAE), which is an animal model of MS, is more severe in Germ-free mice (Ochoa-Repáraz et al., 2009).”
BackgroundInfluentialMori, T., Iwasaki, Y., Seki, Y., Iseki, M., Katayama, H., Yamamoto, K., Takatsu, K., & Takaki, S. (2014) · Journal of Immunology · doi:10.4049/jimmunol.1303243 · Cited by 41
“proved that GM-CSF–producing T cells in so-called Th1 and Th17 cells are pathogenetic and responsible for autoimmunemediated tissue inflammation (46, 47).”
BackgroundDohlman, T. H., Ding, J. X., Dana, R., & Chauhan, S. K. (2017) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-20789 · Cited by 38
The Dynamic Duo–Inflammatory M1 macrophages and Th17 cells in Rheumatic Diseases
Li, J. (2013) · Journal of Orthopedics & Rheumatology · doi:10.13188/2334-2846.1000002 · Cited by 37
“Importantly, the IL-23R-RORγt signaling also promotes the development of the transitional IFN-γ and IL-17 producing CD4 T cell subpopulation, Th1/17 [10], which may be derived from a Th1 population as it undergoes chromatin remodeling.”
BackgroundImmunotherapeutic Implication of IL-6 Blockade
Tanaka, T., & Kishimoto, T. (2011) · Immunotherapy · doi:10.2217/imt.11.147 · Cited by 39
miRNAs Alter T Helper 17 Cell Fate in the Pathogenesis of Autoimmune Diseases
Huang, J., Xu, X., & Yang, J. Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.593473 · Cited by 38
“Moreover, infiltrating Th17 cells secrete GM-CSF, which recruits DCs and macrophages to promote and sustain tissue inflammation (3, 77).”
BackgroundMindur, J. E., Ito, N., Dhib-Jalbut, S., & Ito, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099068 · Cited by 32
Chemokine receptor expression by inflammatory T cells in EAE
Mony, J. T., Khorooshi, R., & Owens, T. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00187 · Cited by 37
“This was also true for GM-CSF, a cytokine that has been implicated as a direct encephalitogenic mediator in EAE (Kroenke et al., 2010; Codarri et al., 2011).”
BackgroundThe helminth Trichuris suis suppresses TLR4-induced inflammatory responses in human macrophages
Ottow, M., Klaver, E. J., Kraan, T. C. T. M. V. D. P., Heijnen, P. D. A. M., Laan, L. C., Kringel, H., Vogel, D. Y. S., Dijkstra, C. D., Kooij, G., & van Die, I. (2014) · Genes and Immunity · doi:10.1038/gene.2014.38 · Cited by 35
Vitamin D Counteracts an IL-23–Dependent IL-17A+IFN- γ + Response Driven by Urban Particulate Matter
Mann, E. H., Ho, T.-R., Pfeffer, P., Matthews, N. C., Chevretton, E. B., Mudway, I., Kelly, F. J., & Hawrylowicz, C. M. (2017) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0409oc · Cited by 37
IL ‐17 signaling induces iNOS + microglia activation in retinal vascular diseases
Zhou, T., Liu, Y., Yang, Z., Ni, B., Zhu, X., Huang, Z., Xu, H., Feng, Q., Lin, X., He, C., et al. (2021) · Glia · doi:10.1002/glia.24063 · Cited by 38
“GM-CSF was identified to be derived from Th17 cells and T cell-derived GM-CSF is instrumental in driving inflammation in the central nervous system (Codarri et al., 2011; El-Behi et al., 2011).”
BackgroundHuang, G., Wang, Y., Vogel, P., & Chi, H. (2015) · Science Signaling · doi:10.1126/scisignal.aaa2147 · Cited by 37
“In particular, GM-CSF produced by TH17 cells is a key stimulator of the encephalitogenic program (5, 6).”
Purinergic Signaling as a Regulator of Th17 Cell Plasticity
Fernández, D., Flores‐Santibáñez, F., Neira, J., Osorio‐Barrios, F., Tejón, G., Núñez, S., Hidalgo, Y., Fuenzalida, M. J., Meza, D., Ureta, G., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157889 · Cited by 39
“Other studies revealed that the encephalitogenic properties of Th17 cells depend on GM-CSF production [23,25], whereas IL-10 production has been strongly related to non-pathogenic Th17 cells in EAE [18].”
BackgroundRole of GM-CSF in lung balance and disease
Chen, Y., Li, F., Hua, M., Liang, M., & Song, C. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1158859 · Cited by 40
“Studies now show that GM-CSF has a wide range of biological activities in innate and adaptive immunity, and it plays a key role in many autoimmune and inflammatory diseases (2, 3).”
BackgroundTahvili, S., Zandieh, B., & Amirghofran, Z. (2015) · International Journal of Dermatology · doi:10.1111/ijd.12834 · Cited by 39
Lee, P. W., Yang, Y., Racke, M. K., & Lovett‐Racke, A. E. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.12.007 · Cited by 37
The essential role of t cells in multiple sclerosis: A reappraisal
Constantinescu, C. S., & Gran, B. (2014) · Biomedical Journal · doi:10.4103/2319-4170.128746 · Cited by 36
Mangalam, A. K., Rattan, R., Suhail, H., Singh, J., Hoda, M. N., Deshpande, M., Fulzele, S., Đenić, A., Shridhar, V., Kumar, A., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501549 · Cited by 34
“Our data are in agreement with recent studies showing the key pathological role of GM-CSF for both Th1- and Th17-mediated demyelinating disease (33, 45, 46).”
BackgroundResultInfluentialWei, Y., Chen, S., Sun, D., Li, X., Wei, R., Li, X., & Nian, H. (2019) · The FASEB Journal · doi:10.1096/fj.201901446r · Cited by 36
“KEY WORDS: IL-23 • pathogenic Th17 cells • IL-23R • GM-CSF • IL-22 T helper (Th)17 cells are critically involved in the pathogenesis of various autoimmune disorders, including uveitis and its animal model, experimental autoimmune uveitis (EAU) (1–3).”
BackgroundInfluentialJarjour, N. N., Bradstreet, T. R., Schwarzkopf, E. A., Cook, M. E., Lai, C., Huang, S. C., Taneja, R., Stappenbeck, T. S., Dyken, S. J. V., Urban, J. F., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1900978 · Cited by 36
Deubiquitinating enzymes (DUBs): DoUBle-edged swords in CNS autoimmunity
Ruan, J., Schlüter, D., & Wang, X. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01783-8 · Cited by 38
Increased CD8+ T cell responses to apoptotic T cell-associated antigens in multiple sclerosis
Lolli, F., Martini, H., Citro, A., Franceschini, D., Portaccio, E., Amato, M. P., Mechelli, R., Annibali, V., Sidney, J., Sette, A., et al. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-94 · Cited by 36
“; licensee BioMed Central Ltd Commons Attribution License (http://creativec reproduction in any medium, provided the or IL-17 produced by CD4 or CD8 T cells specific to myelin proteins (likely in response to IL-23 and granulocyte monocyte-colony stimulating factor, GM-CSF) plays a preponderant role in the autoimmune d…”
BackgroundPham, D., Walline, C. C., Hollister, K., Dent, A. L., Blum, J. S., Firulli, A. B., & Kaplan, M. H. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.497248 · Cited by 35
“Twist1fl/flCD4-Cre mice manifested severe clinical symptom of MOG-induced EAE than wild type mice, although maximal severity and recovery were similar (Fig.”
BackgroundInfluentialLee, P., Puppi, M., Schluns, K. S., Yu‐Lee, L., Dong, C., & Lacorazza, H. D. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301372 · Cited by 35
“Hence, loss of ELF4 worsened clinical symptoms of EAE at least in part by increasing infiltration of Th17 cells to the brain.”
BackgroundInfluentialGuo, X., Higgs, B., Bay-Jensen, A., Wu, Y.-L., Karsdal, M., Kuziora, M., Godwood, A., Close, D., Ryan, P. C., Roskos, L., et al. (2018) · Rheumatology · doi:10.1093/rheumatology/kex383 · Cited by 37
Cytokine Regulation in Human CD4 T Cells by the Aryl Hydrocarbon Receptor and Gq-Coupled Receptors
McAleer, J. P., Fan, J., Roar, B., Primerano, D. A., & Denvir, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-29262-4 · Cited by 37
Lack of Ikaros Deregulates Inflammatory Gene Programs in T Cells
Ana, C. L. D., Arakcheeva, K., Agnihotri, P., Derosia, N. M., & Winandy, S. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801270 · Cited by 32
Crotti, C., Biggioggero, M., Becciolini, A., Agape, E., & Favalli, E. G. (2019) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2019.1631795 · Cited by 35
“Moreover, GM-CSF has an impact on Th17 cells, contributing to differentiation and activity of these cells, which play a well-established role in RA pathogenesis [40,41].”
BackgroundGooshe, M., Abdolghaffari, A. H., Gambuzza, M. E., & Rezaei, N. (2014) · Reviews in the Neurosciences · doi:10.1515/revneuro-2014-0026 · Cited by 36
Li, D., Zhou, J., Wang, L., Gong, Z., Le, H., Huang, Y., Xu, C., Tian, C., Cai, W., & Wu, J. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01109-0 · Cited by 35
“…up-regulated molecules related to the pathogenicity of Th17 cells, such as CCR6, a chemokine receptor crucial for pro-inflammatory function of Th17 in autoimmune disease involving EAE and arthritis, and GM-CSF as well as GZMB, the critical components of pathogenic Th17 signature [22–24] (Fig.”
BackgroundMangani, D., Subramanian, A., Huang, L., Cheng, H., Krovi, S. H., Wu, Y., Yang, D., Moreira, T. G., Escobar, G., Schnell, A., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.09.017 · Cited by 35
Cravens, P. D., Hussain, R. Z., Zacharias, T., Ben, L.-H., Herndon, E., Vinnakota, R., Lambracht‐Washington, D., Nessler, S., Zamvil, S. S., Eagar, T. N., et al. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-73 · Cited by 34
“Other investigators recently showed that GM-CSF may play critical role in different models of active and passive EAE [41-43].”
Chorioamnionitis, IL‐17A, and fetal origins of neurologic disease
Lawrence, S. M., & Wynn, J. L. (2017) · American Journal of Reproductive Immunology · doi:10.1111/aji.12803 · Cited by 33
Ansari, M. A., Nadeem, A., Alshammari, M. A., Attia, S. M., Bakheet, S. A., Khan, M. R., Albekairi, T. H., Alasmari, A. F., Alhosaini, K. A., Alqahtani, F., et al. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.113997 · Cited by 35
Targeting Th17 Effector Cytokines for the Treatment of Autoimmune Diseases
Yamagata, T., Skepner, J. E., & Yang, J. (2015) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-015-0362-x · Cited by 37
Núñez, S., Sáez, J. J., Fernández, D., Flores‐Santibáñez, F., Alvarez, K. L. F., Tejón, G., Ruiz, P., Villavicencio, P. M., Hidalgo, Y., Manrı́quez, V., et al. (2012) · Immunology · doi:10.1111/imm.12055 · Cited by 41
Mesenchymal stem cells are mobilized from the bone marrow during inflammation
Koning, J. J., Kooij, G., de Vries, H. E., Nolte, M. A., & Mebius, R. E. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00049 · Cited by 34
“Activated CD4 T cells in the CNS, which produce pro-inflammatory molecules such as IFN-y, TNF-α, IL-17, lymphotoxin, and GM-CSF, are considered to play a central role in the pathogenesis of MS and EAE (Zamvil and Steinman, 1990; Sospedra and Martin, 2005; Segal, 2010; Codarri et al., 2011).”
BackgroundInfluentialAdrenomedullin protects from experimental autoimmune encephalomyelitis at multiple levels
Pedreño, M., Morell, M., Robledo, G., Souza-Moreira, L., Forte-Lago, I., Caro, M., O'Valle, F., Ganea, D., & González-Rey, E. (2013) · Brain, behavior, and immunity · doi:10.1016/j.bbi.2013.11.021 · Cited by 27
“…and osteopontin by encephalitogenic T cells, since both cytokines serve a nonredundant function in the initiation of autoimmune inflammation and in the generation of Th1 and Th17 cells in EAE and MS (Codarri et al., 2011; Chabas et al., 2001; Jansson et al., 2002; Murugaiyan et al., 2008, 2010).”
BackgroundThe Role of Granulocyte-Macrophage Colony-Stimulating Factor in Murine Models of Multiple Sclerosis
Monaghan, K. L., & Wan, E. C. K. (2020) · Cells · doi:10.3390/cells9030611 · Cited by 35
“The role of Th17 cells in EAE is further supported by an elegant study that demonstrated that the upregulation of both IL-23 and RORγt license the Th17 cells to produce GM-CSF.”
BackgroundInfluentialImmunotherapy of aspergillosis
Carvalho, A., Cunha, C., Bistoni, F., & Romani, L. R. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03681.x · Cited by 33
Oncogenic kinase inhibition limits Batf3-dependent dendritic cell development and antitumor immunity
Medina, B. D., Liu, M., Vitiello, G. A., Seifert, A. M., Zeng, S., Bowler, T. G., Zhang, J. Q., Cavnar, M. J., Loo, J. K., Param, N. J., et al. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20180660 · Cited by 34
“Secretion of GM-CSF and IL-17 and expression of RORγt can be regulated by IL-1β or IL-23p19 (Codarri et al., 2011; Lukens et al., 2012; Wu et al., 2016).”
Chen, J., Martindale, J. L., Abdelmohsen, K., Kumar, G., Fortina, P. M., Gorospe, M., Rostami, A. M., & Yu, S. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1900769 · Cited by 34
“with reports that GM-CSF is a critical cytokine for the pathogenicity of Th17 cells in EAE (4, 34, 40) and extend our previous report to better understand the mechanism by which HuR plays a critical role in Th17 cells.”
BackgroundThe hedgehog pathway suppresses neuropathogenesis in CD4 T cell-driven inflammation
Benallegue, N., Kébir, H., Kapoor, R., Crockett, A. M., Li, C., Cheslow, L., Abdel-Hakeem, M. S., Gesualdi, J., Miller, M. C., Wherry, E. J., et al. (2021) · Brain · doi:10.1093/brain/awab083 · Cited by 31
“Next, we determined whether SMO deficiency in CD4 T cells could alter their immunopathological response within the inflamed CNS.”
BackgroundInfluentialLi, R., & Bar‐Or, A. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a029108 · Cited by 32
“2001) and GM-CSF-deficient Th17 cells fail to induce passive EAE (Ponomarev et al. 2007; Codarri et al. 2011; El-Behi et al. 2011).”
BackgroundBucher, C. H., Berkmann, J. C., Burkhardt, L.-M., Paschke, C., Schlundt, C., Lang, A., Wolter, A., Damerau, A., Geißler, S., Volk, H., et al. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00834-9 · Cited by 36
Guéry, J., Lélu, K., Laffont, S., & Garnier, L. (2015) · Biomedical Journal · doi:10.4103/2319-4170.158509 · Cited by 35
Jiao, Z., Bedoui, S., Brady, J. L., Walter, A., Chopin, M., Carrington, E. M., Sutherland, R. M., Nutt, S. L., Zhang, Y., Ko, H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091126 · Cited by 32
Montes‐Cobos, E., Schweingruber, N., Li, X., Fischer, H. J., Reichardt, H. M., & Lühder, F. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01319 · Cited by 32
Cook, A. D., & Hamilton, J. A. (2018) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x17752036 · Cited by 32
Sen, S., He, Z.-H., Ghosh, S., Dery, K. J., Yang, L.-M., Zhang, J., & Sun, Z.-M. (2018) · Journal of Immunology · doi:10.4049/jimmunol.1701654 · Cited by 28
“For visualization of CNS infiltration by cells of the immune system and demyelination, spinal cords of mice in which EAE was induced were collected on day 15.”
BackgroundInfluentialDimitrijević, M., Arsenović-Ranin, N., Kosec, D. J., Bufan, B., Nacka-Aleksić, M., Pilipović, I., & Leposavić, G. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.11.311 · Cited by 32
Laouarem, Y., Kassoussi, A., Zahaf, A., Hutteau-Hamel, T., Mellouk, A., Bobé, P., Mattern, C., Schumacher, M., & Traiffort, É. (2021) · Glia · doi:10.1002/glia.23967 · Cited by 31
“Furthermore, the IL-1β decrease induced by the drug combination is also consistent with the decrease of GM-CSF since IL-1β has been previously reported to be one of the cytokines that are indispensable for the production of GMCSF and thus pathogenic T cell generation in the EAE model (El-Behi et al., 2011; Komuczki et…”
BackgroundInfluentialTetramerization of STAT5 promotes autoimmune-mediated neuroinflammation
Monaghan, K. L., Aesoph, D., Ammer, A. G., Zheng, W., Rahimpour, S., Farris, B. Y., Spinner, C. A., Li, P., Lin, J., Yu, Z., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2116256118 · Cited by 31
Dutra, M. L., Dias, P., Freiberger, V., Ventura, L., Comim, C. M., Martins, D. F., & Bobinski, F. (2022) · Neuroscience Letters · doi:10.1016/j.neulet.2022.136974 · Cited by 33
Mangan, P. R., Su, L. J., Jenny, V., Tatum, A. L., Picarillo, C., Skala, S., Ditto, N. T., Lin, Z., Yang, X., Cotter, P., et al. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.224246 · Cited by 32
“IL-23 induces additional proinflammatory cytokines such as IL-22 andGM-CSF, which have been shown to bemore critical than IL-17 to the pathology of certain animal disease models (Liang et al., 2006; Zheng et al., 2007; van der Fits et al., 2009; Codarri et al., 2011; El-Behi et al., 2011).”
BackgroundStimulation of Adult Oligodendrogenesis by Myelin-Specific T Cells
Nielsen, H. H., Toft‐Hansen, H., Lambertsen, K. L., Owens, T., & Finsen, B. R. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.06.006 · Cited by 35
Oral zinc aspartate treats experimental autoimmune encephalomyelitis
Schubert, C., Guttek, K., Grüngreiff, K., Thielitz, A., Bühling, F., Reinhold, A., Brocke, S., & Reinhold, D. (2014) · BioMetals · doi:10.1007/s10534-014-9786-8 · Cited by 33
“Key pathogenic roles in this process were attributed to the Th1 cytokine IFN-c, the Th17 cytokine IL-17 and GM-CSF (Codarri et al. 2011; El-Behi et al. 2011).”
BackgroundInfluentialTh17 Cells Induce Th1-Polarizing Monocyte-Derived Dendritic Cells
Davidson, M. G., Alonso, M. N., Yuan, R. T., Axtell, R. C., Kenkel, J. A., Suhoski, M. M., González, J. C., Steinman, L., & Engleman, E. G. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203201 · Cited by 32
“Th cell production of GM-CSF has been implicated as a driver of pathogenesis in EAE (15, 31).”
BackgroundDefining the functional states of Th17 cells
Lee, Y., & Kuchroo, V. K. (2015) · F1000Research · doi:10.12688/f1000research.6116.1 · Cited by 32
“IL-23 inhibits IL-10 production and instead promotes secretion of IL-22 and GM-CSF, suggesting that IL-23 drives the development of Th17 cells with unique functional properties 59–61 .”
Dey, I., & Bishayi, B. (2017) · Microbial Pathogenesis · doi:10.1016/j.micpath.2017.10.033 · Cited by 22
Metadata
- Authors
- Codarri, L., Gyülvészi, G., Tosevski, V., Hesske, L., Fontana, A., Magnenat, L., Suter, T., & Becher, B.
- Affiliations
- University Hospital Zurich (CH)
- University of Zurich (CH)
- Merck Serono S.A. (Switzerland) (CH)
- Corresponding author
- Becher, Burkhard
- Venue
- Nature Immunology
- Published
- 2011-04-24
- Volume
- 12
- Issue
- 6
- Pages
- 560-567
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W2157837362
- Cited by
- 1,191
- References
- 44
- Citations by year
- 2026: 31 · 2025: 48 · 2024: 60 · 2023: 53 · 2022: 61 · 2021: 73 · 2020: 85 · 2019: 83 · 2018: 72 · 2017: 99 · 2016: 96 · 2015: 117 · 2014: 103 · 2013: 98 · 2012: 82
- FWCI
- 70.23
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- RORγt, GM-CSF, experimental autoimmune encephalomyelitis, T helper cells, IL-23, autoimmune neuroinflammation, Th1 cells, Th17 cells, myeloid cell infiltration, IL-12, interferon-gamma, IL-27, cytokine regulation
- MeSH terms
- Animals, Cells, Cultured, Encephalomyelitis, Autoimmune, Experimental, Female, Flow Cytometry, Glycoproteins, T-Lymphocytes, Helper-Inducer, Interferon-gamma, Interleukins, Male, Mice, Inbred C57BL, Mice, Inbred Strains, Mice, Transgenic, Peptide Fragments, Granulocyte-Macrophage Colony-Stimulating Factor, Mice, Knockout, Th1 Cells, Interleukin-12, Interleukin-17, Mice, Interleukin-23, Nuclear Receptor Subfamily 1, Group F, Member 3, Th17 Cells, Myelin-Oligodendrocyte Glycoprotein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review